HENDERSON MICHAEL THOMAS
SEC insider (Form 3/4/5 filer). CIK 0001779990. Director at TCGX Acquisition Corp. II (TCXB) and 2 other issuers. 61 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in PALO ALTO, CA.
Companies HENDERSON MICHAEL THOMAS has filed insider reports for
- TCGX Acquisition Corp. II (TCXB): Director
- Apogee Therapeutics, Inc. (APGE): Director, Officer, Chief Executive Officer
- Spyre Therapeutics, Inc. (SYRE): Director
HENDERSON MICHAEL THOMAS
CIK: 0001779990
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (61 total)
- Sep 3, 2026APGE
Apogee Therapeutics, Inc.
DispositionDirect920.9K shares- - Jul 10, 2026APGE
Apogee Therapeutics, Inc.
GiftDirect75K shares- - Jul 8, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect20K shares at avg. $133.63$2.7M - Jun 22, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect80K shares at avg. $132.54$10.6M - Jun 22, 2026SYRE
Spyre Therapeutics, Inc.
SaleDirect20K shares at avg. $100.00$2.0M - Jun 10, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect7.7K shares at avg. $82.78$634K - Jun 10, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect614 shares at avg. $86.89$53K - Jun 10, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect1.1K shares at avg. $84.18$91K - Jun 10, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect2.3K shares at avg. $86.27$199K - Jun 10, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect6.8K shares at avg. $82.21$557K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  APGE Apogee Therapeutics, Inc. | Disposition | 920,941 | - | $0 | Direct |
| Jul 10, 2026 | APGE Apogee Therapeutics, Inc. | Gift | 75,046 | - | $0 | Direct |
| Jul 8, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 20,000 | $133.63 | $2,672,600 | Direct |
| Jun 22, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 80,000 | $132.54 | $10,603,200 | Direct |
| Jun 22, 2026 |  SYRE Spyre Therapeutics, Inc. | Sale | 20,000 | $100.00 | $2,000,000 | Direct |
| Jun 10, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 7,654 | $82.78 | $633,598 | Direct |
| Jun 10, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 614 | $86.89 | $53,350 | Direct |
| Jun 10, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 1,080 | $84.18 | $90,914 | Direct |
| Jun 10, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 2,305 | $86.27 | $198,852 | Direct |
| Jun 10, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 6,770 | $82.21 | $556,562 | Direct |
1-10 of 61 transactions